vs
Side-by-side financial comparison of Electromed, Inc. (ELMD) and JOINT Corp (JYNT). Click either name above to swap in a different company.
Electromed, Inc. is the larger business by last-quarter revenue ($18.9M vs $15.2M, roughly 1.2× JOINT Corp). Electromed, Inc. runs the higher net margin — 14.6% vs 6.5%, a 8.1% gap on every dollar of revenue. On growth, Electromed, Inc. posted the faster year-over-year revenue change (16.3% vs 3.1%). Electromed, Inc. produced more free cash flow last quarter ($2.4M vs $334.7K). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs -28.6%).
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
The Joint Corp is a leading operator and franchisor of chiropractic care clinics primarily serving the U.S. market. It offers accessible, affordable routine chiropractic services, membership-based care plans, and caters to consumers seeking non-invasive musculoskeletal pain management and wellness support.
ELMD vs JYNT — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.9M | $15.2M |
| Net Profit | $2.8M | $991.1K |
| Gross Margin | 78.4% | 81.4% |
| Operating Margin | 19.2% | 4.9% |
| Net Margin | 14.6% | 6.5% |
| Revenue YoY | 16.3% | 3.1% |
| Net Profit YoY | 40.3% | 5510.5% |
| EPS (diluted) | $0.32 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.9M | $15.2M | ||
| Q3 25 | $16.9M | $13.4M | ||
| Q2 25 | $17.4M | $13.3M | ||
| Q1 25 | $15.7M | $13.1M | ||
| Q4 24 | $16.3M | $14.7M | ||
| Q3 24 | $14.7M | $30.2M | ||
| Q2 24 | $14.8M | $30.3M | ||
| Q1 24 | $13.9M | $29.7M |
| Q4 25 | $2.8M | $991.1K | ||
| Q3 25 | $2.1M | $855.0K | ||
| Q2 25 | $2.2M | $93.4K | ||
| Q1 25 | $1.9M | $967.8K | ||
| Q4 24 | $2.0M | $17.7K | ||
| Q3 24 | $1.5M | $-3.2M | ||
| Q2 24 | $1.8M | $-3.6M | ||
| Q1 24 | $1.5M | $947.0K |
| Q4 25 | 78.4% | 81.4% | ||
| Q3 25 | 78.1% | 80.1% | ||
| Q2 25 | 78.3% | 79.1% | ||
| Q1 25 | 78.0% | 77.3% | ||
| Q4 24 | 77.7% | 78.4% | ||
| Q3 24 | 78.3% | 90.7% | ||
| Q2 24 | 76.2% | 90.7% | ||
| Q1 24 | 74.8% | 90.9% |
| Q4 25 | 19.2% | 4.9% | ||
| Q3 25 | 15.8% | 1.2% | ||
| Q2 25 | 17.5% | -8.6% | ||
| Q1 25 | 13.6% | -5.2% | ||
| Q4 24 | 15.6% | 5.5% | ||
| Q3 24 | 13.2% | -1.6% | ||
| Q2 24 | 15.7% | -5.9% | ||
| Q1 24 | 13.3% | -1.4% |
| Q4 25 | 14.6% | 6.5% | ||
| Q3 25 | 12.6% | 6.4% | ||
| Q2 25 | 12.7% | 0.7% | ||
| Q1 25 | 12.1% | 7.4% | ||
| Q4 24 | 12.1% | 0.1% | ||
| Q3 24 | 10.0% | -10.5% | ||
| Q2 24 | 12.3% | -11.9% | ||
| Q1 24 | 10.8% | 3.2% |
| Q4 25 | $0.32 | $0.06 | ||
| Q3 25 | $0.25 | $0.06 | ||
| Q2 25 | $0.26 | $0.01 | ||
| Q1 25 | $0.21 | $0.06 | ||
| Q4 24 | $0.22 | $0.01 | ||
| Q3 24 | $0.16 | $-0.21 | ||
| Q2 24 | $0.20 | $-0.24 | ||
| Q1 24 | $0.17 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.8M | $23.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $45.4M | $15.1M |
| Total Assets | $54.9M | $61.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.8M | $23.6M | ||
| Q3 25 | $14.1M | $29.7M | ||
| Q2 25 | $15.3M | $29.8M | ||
| Q1 25 | $15.2M | $21.9M | ||
| Q4 24 | $16.2M | $25.1M | ||
| Q3 24 | $13.9M | $20.7M | ||
| Q2 24 | $16.1M | $17.5M | ||
| Q1 24 | $11.7M | $18.7M |
| Q4 25 | $45.4M | $15.1M | ||
| Q3 25 | $44.7M | $22.7M | ||
| Q2 25 | $43.2M | $23.2M | ||
| Q1 25 | $43.9M | $22.8M | ||
| Q4 24 | $43.6M | $20.7M | ||
| Q3 24 | $41.5M | $20.5M | ||
| Q2 24 | $44.5M | $23.2M | ||
| Q1 24 | $42.5M | $26.2M |
| Q4 25 | $54.9M | $61.0M | ||
| Q3 25 | $53.6M | $69.4M | ||
| Q2 25 | $53.8M | $73.2M | ||
| Q1 25 | $52.5M | $80.1M | ||
| Q4 24 | $52.3M | $83.2M | ||
| Q3 24 | $48.9M | $79.6M | ||
| Q2 24 | $52.2M | $82.4M | ||
| Q1 24 | $48.9M | $85.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $1.8M |
| Free Cash FlowOCF − Capex | $2.4M | $334.7K |
| FCF MarginFCF / Revenue | 12.7% | 2.2% |
| Capex IntensityCapex / Revenue | 3.4% | 9.9% |
| Cash ConversionOCF / Net Profit | 1.10× | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $7.9M | $-1.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $1.8M | ||
| Q3 25 | $169.0K | $1.8M | ||
| Q2 25 | $3.9M | $868.6K | ||
| Q1 25 | $2.1M | $-3.7M | ||
| Q4 24 | $3.2M | $9.4M | ||
| Q3 24 | $2.3M | $3.4M | ||
| Q2 24 | $4.5M | $-973.5K | ||
| Q1 24 | $1.4M | $2.8M |
| Q4 25 | $2.4M | $334.7K | ||
| Q3 25 | $-83.0K | $1.5M | ||
| Q2 25 | $3.7M | $363.6K | ||
| Q1 25 | $1.9M | $-4.0M | ||
| Q4 24 | $2.9M | $8.2M | ||
| Q3 24 | $2.3M | $3.2M | ||
| Q2 24 | $4.5M | $-1.2M | ||
| Q1 24 | $1.3M | $2.4M |
| Q4 25 | 12.7% | 2.2% | ||
| Q3 25 | -0.5% | 10.9% | ||
| Q2 25 | 21.4% | 2.7% | ||
| Q1 25 | 12.2% | -30.8% | ||
| Q4 24 | 18.0% | 55.9% | ||
| Q3 24 | 15.5% | 10.6% | ||
| Q2 24 | 30.1% | -4.1% | ||
| Q1 24 | 9.1% | 8.1% |
| Q4 25 | 3.4% | 9.9% | ||
| Q3 25 | 1.5% | 2.4% | ||
| Q2 25 | 0.8% | 3.8% | ||
| Q1 25 | 1.0% | 2.5% | ||
| Q4 24 | 1.4% | 8.1% | ||
| Q3 24 | 0.3% | 0.8% | ||
| Q2 24 | 0.1% | 0.9% | ||
| Q1 24 | 0.6% | 1.3% |
| Q4 25 | 1.10× | 1.86× | ||
| Q3 25 | 0.08× | 2.07× | ||
| Q2 25 | 1.75× | 9.30× | ||
| Q1 25 | 1.10× | -3.82× | ||
| Q4 24 | 1.60× | 532.98× | ||
| Q3 24 | 1.57× | — | ||
| Q2 24 | 2.46× | — | ||
| Q1 24 | 0.90× | 2.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
